Company: RGNX
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0000950170-25-038770
Chunk: 230

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 230
---

    Taxes paid related to net settlement of stock-based awards

    (910
    )

    (419
    )

    (284
    )

    Proceeds from issuance of common stock under employee stock purchase plan

    1,191

    1,826

    1,742

    Proceeds from public offering of common stock and pre-funded warrants,   net of issuance costs

    131,067

    —

    —

    Proceeds from private placement of common stock, net of issuance costs

    —

    4,874

    —

    Offering expenses related to at-the-market offering programs

    (323
    )

    (470
    )

    —

    Repayments under liability related to sale of future royalties, net of imputed interest

    (39,854
    )

    (42,298
    )

    (33,102
    )

    Net cash provided by (used in) financing activities

    92,683

    (34,966
    )

    (28,840
    )

    Net increase (decrease) in cash and cash equivalents and restricted cash

    23,004

    (62,430
    )

    (248,257
    )

    Cash and cash equivalents and restricted cash

    Beginning of period

    36,552

    98,982

    347,239

    End of period
     
    $
    59,556

    $
    36,552

    $
    98,982

    Supplemental cash flow information

    Cash paid (received) for income taxes
     
    $
    (72
    )
     
    $
    (142
    )
     
    $
    11,812

    Cash paid for imputed interest under liability related to sale of future royalties
     
    $
    6,559

    $
    7,276

    $
    23,117

The accompanying notes are an integral part of these consolidated financial statements.

93

REGENXBIO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Nature of BusinessREGENXBIO Inc. (the Company) is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company's investigational gene therapies use adeno-associated virus (AAV) vectors from its proprietary gene delivery platform (NAV Technology Platform). The NAV® Technology Platform